Triethylamine → HCID 67621272, 화합물

HRID 2293364노트

반응식

HRID 2293364 반응식
[NH:1]1[CH2:8][CH2:7][CH2:6][C@H:2]1[C:3]([OH:5])=O.[CH2:9]([NH:16][C:17](=[O:24])[C@H:18]([C@H:20]([CH2:22][CH3:23])[CH3:21])[NH2:19])[C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1.C(N(CC)CC)C.Br[CH2:33][C:34]([C:36]1[CH:41]=[CH:40][C:39]([CH3:42])=[CH:38][C:37]=1[CH3:43])=[O:35]>C1COCC1>[CH3:43][C:37]1[CH:38]=[C:39]([CH3:42])[CH:40]=[CH:41][C:36]=1[C:34](=[O:35])[CH2:33][N:1]1[CH2:8][CH2:7][CH2:6][C@H:2]1[C:3]([N:16]([CH2:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1)[C:17](=[O:24])[C@H:18]([C@H:20]([CH2:22][CH3:23])[CH3:21])[NH2:19])=[O:5]

참가 물질

5

반응물 3

HCID 8471TriethylamineHCID 20634502-Bromo-1-(2,4-dimethylphenyl)ethanoneHCID 86751513HCID 86751513, 화합물

생성물 1

HCID 67621272HCID 67621272, 화합물수율 21.6%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

Using the procedure described in Example 5, treatment of a solution of L-proline-L-isoleucine benzylamide (60 mg, 0.19 mmol), with triethylamine (130 uL, 0.94 mmol, 5.0 eq), and 2-bromo-2',4'-dimethylacetophenone (52 mg, 0.23 mmol, 1.2 eq) in THF (7 mL), provided a crude product. A portion of the product was purified by preparative TLC to provide 19 mg (21%) of L-isoleucine, N-[1-(2-(2,4-dimethylphenyl)-2-oxoethyl)-L-prolyl] benzylamide.

후처리

  1. customprovided a crude product
  2. customA portion of the product was purified by preparative TLC

출처 및 근거

ORD 기록
ord-5d2260a5cc324e1cbdb8280635994031
출처 데이터셋
uspto-grants-1997_11
특허 번호
US05686424

반응 노트

불러오는 중…